The DOI matches its Crossref record; 427 of the 427 references it cites were found in a registry or an index.
Androgens and Coronary Artery Disease
Abstract
A significant and independent association between endogenous testosterone (T) levels and coronary events in men and women has not been confirmed in large prospective studies, although cross-sectional data have suggested coronary heart disease can be associated with low T in men. Hypoandrogenemia in men and hyperandrogenemia in women are associated with visceral obesity; insulin resistance; low high-density lipoprotein (HDL) cholesterol (HDL-C); and elevated triglycerides, low-density lipoprotein cholesterol, and plasminogen activator type 1. These gender differences and confounders render the precise role of endogenous T in atherosclerosis unclear. Observational studies do not support the hypothesis that dehydroepiandrosterone sulfate deficiency is a risk factor for coronary artery disease. The effects of exogenous T on cardiovascular mortality or morbidity have not been extensively investigated in prospective controlled studies; preliminary data suggest there may be short-term improvements in electrocardiographic changes in men with coronary artery disease. In the majority of animal experiments, exogenous T exerts either neutral or beneficial effects on the development of atherosclerosis. Exogenous androgens induce both apparently beneficial and deleterious effects on cardiovascular risk factors by decreasing serum levels of HDL-C, plasminogen activator type 1 (apparently deleterious), lipoprotein (a), fibrinogen, insulin, leptin, and visceral fat mass (apparently beneficial) in men as well as women. However, androgen-induced declines in circulating HDL-C should not automatically be assumed to be proatherogenic, because these declines may instead reflect accelerated reverse cholesterol transport. Supraphysiological concentrations of T stimulate vasorelaxation; but at physiological concentrations, beneficial, neutral, and detrimental effects on vascular reactivity have been observed. T exerts proatherogenic effects on macrophage function by facilitating the uptake of modified lipoproteins and an antiatherogenic effect by stimulating efflux of cellular cholesterol to HDL. In conclusion, the inconsistent data, which can only be partly explained by differences in dose and source of androgens, militate against a meaningful assessment of the net effect of T on atherosclerosis. Based on current evidence, the therapeutic use of T in men need not be restricted by concerns regarding cardiovascular side effects. Available data also do not justify the uncontrolled use of T or dehydroepiandrosterone for the prevention or treatment of coronary heart disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 401–427 of 427
Sobel, M. I., Winkel, C. A., Macy, L. B., et al. (1995) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(95)90344-5 · Cited by 30
The Treatment of Angina Pectoris with Testosterone Propionate
Waldman, S. (1945) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-5-7-305 · Cited by 29
Prevalence of a positive family history of type 2 diabetes in women with polycystic ovarian disease
Fox, R. (1999) · Gynecological Endocrinology · doi:10.3109/09513599909167585 · Cited by 28
Tomita, T., Sawamura, F., Uetsuka, R., Chiba, T., Miura, S., Ikeda, M., & Tomita, I. (1996) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(96)00009-4 · Cited by 28
Denti, L., Pasolini, G., Cortellini, P., Ferretti, S., Sanfelici, L., Ablondi, F., & Valenti, G. (1996) · Clinical Chemistry · doi:10.1093/clinchem/42.8.1176 · Cited by 27
Metabolic Aspects of Polycystic Ovary Syndrome
Wild, R. A. (1997) · Seminars in Reproductive Medicine · doi:10.1055/s-2007-1016293 · Cited by 27
Abnormalities of fuel metabolism in the polycystic ovary syndrome.
Wortsman, J., & Ng, S. (1982) · PubMed · Cited by 27
Furutama, D., Fukui, R., Amakawa, M., & Ohsawa, N. (1998) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(97)00085-9 · Cited by 26
Elevated low-density lipoprotein-cholesterol in women with polycystic ovary syndrome
von Eckardstein, S., von Eckardstein, A., Bender, H. G., Schulte, H., & Assmann, G. (1996) · Gynecological Endocrinology · doi:10.3109/09513599609012817 · Cited by 23
Penttilä, T., Koskinen, P. J., Penttilä, T.-A., Anttila, L., & Irjala, K. M. A. (1999) · Fertility and Sterility · doi:10.1016/s0015-0282(98)00473-7 · Cited by 23
Denti, L., Pasolini, G., Cortellini, P., Sanfelici, L., Benedetti, R., Cecchetti, A., Ferretti, S., Bruschieri, L., Ablondi, F., & Valenti, G. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00442-6 · Cited by 22
The Treatment of Angina Pectoris with Testosterone Propionate
Lesser, M. A. (1943) · New England Journal of Medicine · doi:10.1056/nejm194302112280603 · Cited by 22
Primary Cultures of Human Synovial Macrophages Metabolize Androgensa
Cutolo, M., Villaggio, B., BARONE, A., Sulli, A., Accardo, S., Granata, O. M., & CASTAGNETTA, L. A. M. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb16277.x · Cited by 21
Sex hormones and vascular reactivity
Hutchison, S. J., Sudhir, K., Chou, T. M., & Chatterjee, K. (1997) · Herz · doi:10.1007/bf03044351 · Cited by 20
Treatment of prostate cancer with gonadotropin-releasing hormone analogue: effect on lipoprotein[a]
Arrer, E., Jungwirth, A., Mack, D., Frick, J., & Patsch, W. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.7.8675568 · Cited by 20
Rabijewski, M., Adamkiewicz, M., & Zgliczyński, S. (1998) · PubMed · Cited by 18
Rice, T., Sprecher, D. L., Borecki, I. B., Mitchell, L. E., Laskarzewski, P. M., & Rao, D. C. (1993) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320470421 · Cited by 15
Blumenthal, R. S., Brinker, J., Resar, J. R., Gloth, S. T., Zacur, H. A., Coombs, V. J., Gerstenblith, G., & Reís, S. E. (1997) · American Heart Journal · doi:10.1016/s0002-8703(97)70227-8 · Cited by 13
Concentration of Lipid, apoprotein-B and testosterone in patients with coronarographic findings
Hromadová, M., Hácik, T., & Riečanský, I. (1985) · Journal of Molecular Medicine · doi:10.1007/bf01739675 · Cited by 13
Insulin sensitizing agents and polycystic ovary syndrome
Pasquali, R., & Filicori, M. (1998) · European Journal of Endocrinology · doi:10.1530/eje.0.1380253 · Cited by 13
Valdemarsson, S. V., Hedner, P., & Nilsson‐Ehle, P. (1987) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1987.tb03357.x · Cited by 12
Sewdarsen, M., Jialal, I., & Naidu, R. (1988) · Postgraduate Medical Journal · doi:10.1136/pgmj.64.750.264 · Cited by 10
藤本, 良. (1994) · Medical Entomology and Zoology · doi:10.11501/3106845 · Cited by 10
Some measures of lipid metabolism in young sterile males before and after testosterone treatment.
Hromadová, M., Hácik, T., Malatinský, E., Sklovský, A., & Cervenakov, I. (1989) · PubMed · Cited by 10
Treatment of Angina Pectoris and Peripheral Vascular Disease with Sex Hormones.
STRONG, G. F., & Wallace, A. W. (1944) · PubMed · Cited by 8
Treatment of angina pectoris and coronary artery disease with sex hormones
(1942) · American Heart Journal · doi:10.1016/s0002-8703(42)90412-5 · Cited by 7
Hána, V., Marek, J., Češka, R., Sobra, J., Hampl, R., & Stárka, L. (1991) · PubMed · Cited by 3
Cited by
Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline.
Bhasin, S., Brito, J. P., Cunningham, G. R., Hayes, F. J., Hodis, H. N., Matsumoto, A. M., Snyder, P. J., Swerdloff, R. S., Wu, F. C., & Yialamas, M. A. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00229 · Cited by 1,736
Self-citationMolecular and Cellular Basis of Cardiovascular Gender Differences
Mendelsohn, M. E., & Karas, R. H. (2005) · Science · doi:10.1126/science.1112062 · Cited by 1,101
The Decline of Androgen Levels in Elderly Men and Its Clinical and Therapeutic Implications
Kaufman, J. M., & Vermeulen, A. (2005) · Endocrine Reviews · doi:10.1210/er.2004-0013 · Cited by 1,079
Khaw, K.-T., Dowsett, M., Folkerd, E., Bingham, S., Wareham, N., Luben, R., Welch, A., & Day, N. (2007) · Circulation · doi:10.1161/circulationaha.107.719005 · Cited by 743
Genome-wide association analysis of metabolic traits in a birth cohort from a founder population
Sabatti, C., Service, S. K., Hartikainen, A.-L., Pouta, A., Ripatti, S., Brodsky, J., Jones, C. G., Zaitlen, N. A., Varilo, T., Kaakinen, M., et al. (2009) · Nature Genetics · doi:10.1038/ng.271 · Cited by 736
Metadata
- Authors
- Wu, F. C. W., & von Eckardstein, A.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2003-04-01
- Volume
- 24
- Issue
- 2
- Pages
- 183-217
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2066946777
- Cited by
- 592
- References
- 427
- FWCI
- 25.99
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.